Medtronic Statistics

Total Valuation

Medtronic has a market cap or net worth of GBP 91.86 billion. The enterprise value is 106.64 billion.

Market Cap	91.86B
Enterprise Value	106.64B

Important Dates

The last earnings date was Tuesday, February 17, 2026.

Earnings Date	Feb 17, 2026
Ex-Dividend Date	Dec 26, 2025

Share Statistics

Current Share Class	1.28B
Shares Outstanding	n/a
Shares Change (YoY)	-0.83%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	87.01%
Float	1.28B

Valuation Ratios

The trailing PE ratio is 27.03 and the forward PE ratio is 16.07.

PE Ratio	27.03
Forward PE	16.07
PS Ratio	3.51
PB Ratio	2.53
P/TBV Ratio	n/a
P/FCF Ratio	23.05
P/OCF Ratio	17.12
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.63, with an EV/FCF ratio of 26.76.

EV / Earnings	31.38
EV / Sales	4.02
EV / EBITDA	14.63
EV / EBIT	21.49
EV / FCF	26.76

Financial Position

The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.57.

Current Ratio	2.54
Quick Ratio	1.55
Debt / Equity	0.57
Debt / EBITDA	2.88
Debt / FCF	5.19
Interest Coverage	9.30

Financial Efficiency

Return on equity (ROE) is 9.39% and return on invested capital (ROIC) is 7.98%.

Return on Equity (ROE)	9.39%
Return on Assets (ROA)	4.57%
Return on Invested Capital (ROIC)	7.98%
Return on Capital Employed (ROCE)	8.09%
Weighted Average Cost of Capital (WACC)	7.08%
Revenue Per Employee	275,162
Profits Per Employee	35,772
Employee Count	95,000
Asset Turnover	0.39
Inventory Turnover	2.07

Taxes

In the past 12 months, Medtronic has paid 679.96 million in taxes.

Income Tax	679.96M
Effective Tax Rate	16.59%

Stock Price Statistics

The stock price has increased by +3.04% in the last 52 weeks. The beta is 0.72, so Medtronic's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	+3.04%
50-Day Moving Average	98.98
200-Day Moving Average	94.18
Relative Strength Index (RSI)	42.62
Average Volume (20 Days)	5,721

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.25

Income Statement

In the last 12 months, Medtronic had revenue of GBP 26.14 billion and earned 3.40 billion in profits. Earnings per share was 2.64.

Revenue	26.14B
Gross Profit	17.03B
Operating Income	4.88B
Pretax Income	4.10B
Net Income	3.40B
EBITDA	6.95B
EBIT	4.88B
Earnings Per Share (EPS)	2.64

Full Income Statement

Balance Sheet

The company has 6.18 billion in cash and 20.68 billion in debt, giving a net cash position of -14.40 billion.

Cash & Cash Equivalents	6.18B
Total Debt	20.68B
Net Cash	-14.40B
Net Cash Per Share	n/a
Equity (Book Value)	36.24B
Book Value Per Share	28.12
Working Capital	10.74B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.37 billion and capital expenditures -1.38 billion, giving a free cash flow of 3.99 billion.

Operating Cash Flow	5.37B
Capital Expenditures	-1.38B
Free Cash Flow	3.99B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 65.16%, with operating and profit margins of 18.68% and 13.00%.

Gross Margin	65.16%
Operating Margin	18.68%
Pretax Margin	15.67%
Profit Margin	13.00%
EBITDA Margin	26.60%
EBIT Margin	18.68%
FCF Margin	15.25%

Dividends & Yields

This stock pays an annual dividend of 2.11, which amounts to a dividend yield of 2.20%.

Dividend Per Share	2.11
Dividend Yield	2.20%
Dividend Growth (YoY)	-2.87%
Years of Dividend Growth	n/a
Payout Ratio	78.65%
Buyback Yield	0.83%
Shareholder Yield	3.03%
Earnings Yield	3.70%
FCF Yield	4.34%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medtronic has an Altman Z-Score of 2.98 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.98
Piotroski F-Score	6